Prucalopride an Effective Adjunct to PEG for Colonoscopy Bowel Prep Edited by Mandeep Singh Rawat May 20, 2026

https://www.medscape.com/viewarticle/prucalopride-effective-adjunct-peg-colonoscopy-bowel-prep-2026a1000gbi

Declare Climate Change a Public Health Emergency, EU Experts Sophie Cousins logo Medscape Europe May 20, 2026

https://www.medscape.com/viewarticle/declare-climate-change-public-health-emergency-eu-experts-2026a1000gdo

A Revolutionary Cancer Treatment Could Transform Autoimmune Disease Amber Dance May 20, 2026

https://www.medscape.com/s/viewarticle/revolutionary-cancer-treatment-could-transform-autoimmune-2026a1000g9o

Charting New Frontiers in Advanced Breast Cancer: Milestones, Missions, and Mastery Authors: Paolo Tarantino, MD, PhD; Kevin Kalinsky, MD, MS, FASCO; Sibylle Loibl, MD, PhD

https://www.medscape.org/viewarticle/charting-new-frontiers-advanced-breast-cancer-milestones-2026a1000fu7?page=1

Endometriosis research shifts toward earlier diagnosis and personalized treatment After decades of slow progress, advances in molecular profiling and organoid technology are creating new pathways for non-invasive diagnosis and targeted treatment of endometriosis. Written byBree Foster, PhD

https://www.drugdiscoverynews.com/endometriosis-research-shifts-toward-earlier-diagnosis-and-personalized-treatment-16975?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-8teyMc6F1ooE8hwM22Ji3dwzxwBZy0PQawbzb58I-GaOyph1kv0mteY0uoqlcFcm0HiQkyoIv1tYl5Px2sOnmrZZxbbw&_hsmi=419534051&utm_content=419534051&utm_source=hs_email Endometriosis is traditionally defined as the presence of endometrium-like tissue outside the uterus. While clinically precise, this definition obscures the reality of a disorder that is far more complex than ectopic tissue alone. Endometriosis is now understood as a chronic, multisystem, neuro-inflammatory disease — one that disrupts immune, endocrine, and nervous system function and manifests through pain, fatigue, infertility, and profound reductions in quality of life.

First commercially available blood test for endometriosis This new test offers clinicians a tool to detect endometriosis in patients whose lesions may be missed by standard imaging, helping address years-long delays in diagnosis. Written byBree Foster, PhD

https://www.drugdiscoverynews.com/first-commercially-available-blood-test-for-endometriosis-17094?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz--L2v_xFxrxrNEE4wbeNp0k_mDXY_-zmY4RFXdmkYcOylRf627E2MMOwifqSjhNz5Kcn_rP8_44SWH2hGq0tAomQiMKDA&_hsmi=419534051&utm_content=419534051&utm_source=hs_email Endometriosis is a chronic neuroinflammatory disorder affecting over 190 million women worldwide. Characterized by the growth of endometrial-like tissue outside the uterus, the condition manifests as peritoneal, ovarian, or deep lesions, most commonly in the pelvis. Patients experience persistent pelvic pain, often worse during menstruation, as well as fatigue, gastrointestinal and urinary symptoms, mood disorders, and in many cases, infertility. Studies estimate that 30-50 percent of patients with endometriosis face difficulties conceiving.

Is this the first disease-modifying treatment for endometriosis? Endometriosis is still largely managed with pain relief, hormones, and surgery, but a new precision peptide therapy seeks to directly target the underlying lesion biology. Written byBree Foster, PhD

https://www.drugdiscoverynews.com/is-this-the-first-disease-modifying-treatment-for-endometriosis-17177 After visiting 10 doctors in New York City, Tanya Petrossian was told she had ovarian cancer. She moved back to California to be close to her family, preparing for surgery and the possibility that her life was about to change permanently.